← Evidence map

ArticleBone marrow transplantation2026

Multicenter validation of the newly developed Concise Objectifiable Risk Evaluation (CORE) score also confirms its ability to complement the Hematopoietic Cell Comorbidity Index (HCT-CI).

Gunnar Weise et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Multicenter validation of the newly developed Concise Objectifiable Risk Evaluation (CORE) score also confirms its ability to complement the Hematopoietic Cell Comorbidity Index (HCT-CI). | OpenQuestion